In patients with FD, the increase in IL-5 and IL-13 levels also indicates that this process has Th2-type immune response characteristics (85), which is very similar to the increased expression of IL-5 in CD4+ T cells in patients with EoE (86). The gene discussed is IL5; the disease is Fabry disease.